HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Major response to imatinib and chemotherapy in a newborn patient prenatally diagnosed with generalized infantile myofibromatosis.

AuthorsStéphanie Proust, Gabriel Benchimol, Sylvie Fraitag, Julie Starck, Vannina Giacobbi, Gaelle Pierron, Christine Bodemer, Daniel Orbach
JournalPediatric blood & cancer (Pediatr Blood Cancer) Vol. 68 Issue 1 Pg. e28576 (01 2021) ISSN: 1545-5017 [Electronic] United States
PMID32896962 (Publication Type: Case Reports, Letter)
Chemical References
  • Vinblastine
  • Imatinib Mesylate
  • Methotrexate
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Female
  • Humans
  • Imatinib Mesylate (administration & dosage)
  • Infant, Newborn
  • Male
  • Methotrexate (administration & dosage)
  • Myofibromatosis (congenital, drug therapy, pathology)
  • Prognosis
  • Vinblastine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: